SCHEMBL3414904

SCHEMBL3414904

C(=Cc1ccc(N(c2ccccc2)c2ccc3ccc4c(N(c5ccccc5)c5ccc(C=Cc6ccccc6)cc5)ccc5ccc2c3c54)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 3/20 0.44
APP P05067 2/20 0.39
CTDSP1 Q9GZU7 1/20 0.36
NFE2L2 Q16236 1/20 0.36
CYP19A1 P11511 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
MAPK1 P28482 3/20 0.36
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 3/20 0.36
RAB9A P51151 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 2/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128933 1.00 RELA (0.44) RELAAPPCTDSP1NFE2L2CYP19A1
SCHEMBL13240288 0.90 RELA (0.41) RELAAPPMAOAMEN1MAPT
SCHEMBL13358760 0.90 RELA (0.36) RELAAPPMAOAMEN1MAPT
SCHEMBL8927373 0.87 RELA (0.41) RELAAPPCTDSP1NFE2L2MEN1
SCHEMBL25028082 0.87 RELA (0.44) RELAAPPCTDSP1NFE2L2CYP19A1
SCHEMBL3415611 0.87 RELA (0.44) RELAAPPCTDSP1NFE2L2CYP19A1
SCHEMBL9240984 0.86 APP (0.38) RELAAPPCTDSP1NFE2L2MEN1
SCHEMBL556985 0.86 ALDH1A1 (0.39) MAOAMEN1MAPTKMT2AL3MBTL1
SCHEMBL10066735 0.86 ALDH1A1 (0.39) MAOAMEN1MAPTKMT2AL3MBTL1
SCHEMBL9971758 0.85 RELA (0.46) RELAAPPCTDSP1NFE2L2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7670506-B1 Photoactive compositions for liquid deposition E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-03-02 US disclosed
US-20080160344-A1 Wet processing; thin films; electrolytic cells IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 US disclosed
US-7357991-B2 Mixture of electroluminescent compound and solvent; electrolytic cells IDEMITSU KOSAN CO., LTD. (JP) 2008-04-15 US disclosed
US-20050014017-A1 Mixture of electroluminescent compound and solvent; electrolytic cells IDEMITSU KOSAN CO., LTD. (JP) 2005-01-20 US disclosed
EP-1440959-A1 NOVEL SOLUBLE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2004-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080160344-A1 Wet processing; thin films; electrolytic cells EPCAM, L1CAM, IWS1 RELA 1786/4885APP 1175/4885CTDSP1 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.